The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Doogan Declan since year 2005.
The trader's CIK number is 1704234.
At the time of this reporting, Doogan Declan is the Director of Biohaven Pharmaceutical Holding Co Ltd. .
(stock ticker symbol BHVN).
See this page for all insider trading activities at Biohaven Pharmaceutical Holding Co Ltd. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-01-18||BHVN||Biohaven Pharmaceutical Holding Co Ltd.||Sale||27,935||28.13||785,727|
|2018-01-17||BHVN||Biohaven Pharmaceutical Holding Co Ltd.||Sale||61,256||26.52||1,624,202|
|2018-01-16||BHVN||Biohaven Pharmaceutical Holding Co Ltd.||Sale||38,867||26.83||1,042,801|
|2018-01-12||BHVN||Biohaven Pharmaceutical Holding Co Ltd.||Sale||33,442||26.36||881,531|
|2018-01-11||BHVN||Biohaven Pharmaceutical Holding Co Ltd.||Sale||48,138||26.52||1,276,619|
|2018-01-10||BHVN||Biohaven Pharmaceutical Holding Co Ltd.||Sale||40,362||28.69||1,157,985|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Doogan Declan (Director of Biohaven Pharmaceutical Holding Co Ltd. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.